Volume 10, Issue 5, Pages (May 2003)

Slides:



Advertisements
Similar presentations
Volume 16, Issue 10, Pages (October 2009)
Advertisements

Figure 1. Strategy of CRISPR/Cas9-mediated genome editing in S
Volume 11, Issue 11, Pages (November 2004)
Volume 13, Issue 6, Pages (June 2006)
Volume 19, Issue 9, Pages (September 2012)
Travis S. Young, Pieter C. Dorrestein, Christopher T. Walsh 
Volume 16, Issue 10, Pages (October 2009)
Biosynthesis of the Antitumor Agent Chartreusin Involves the Oxidative Rearrangement of an Anthracyclic Polyketide  Zhongli Xu, Kathrin Jakobi, Katrin.
Volume 15, Issue 7, Pages (July 2008)
Volume 20, Issue 10, Pages (October 2013)
Volume 17, Issue 4, Pages (April 2010)
Volume 20, Issue 6, Pages (June 2013)
Volume 13, Issue 4, Pages (April 2006)
Volume 17, Issue 2, Pages (February 2010)
Volume 9, Issue 3, Pages (March 2002)
Mechanism of Thioesterase-Catalyzed Chain Release in the Biosynthesis of the Polyether Antibiotic Nanchangmycin  Tiangang Liu, Xin Lin, Xiufen Zhou, Zixin.
Volume 108, Issue 6, Pages (March 2002)
Volume 19, Issue 2, Pages (February 2012)
Volume 22, Issue 4, Pages (April 2015)
Volume 14, Issue 5, Pages (May 2007)
Functional Dissection of sRNA Translational Regulators by Nonhomologous Random Recombination and In Vivo Selection  Jane M. Liu, Joshua A. Bittker, Maria.
Elucidation of the Biosynthetic Gene Cluster and the Post-PKS Modification Mechanism for Fostriecin in Streptomyces pulveraceus  Rixiang Kong, Xuejiao.
Volume 22, Issue 2, Pages (February 2015)
Volume 19, Issue 3, Pages (March 2012)
Volume 13, Issue 9, Pages (September 2006)
Volume 14, Issue 2, Pages (February 2007)
Liujie Huo, Shwan Rachid, Marc Stadler, Silke C. Wenzel, Rolf Müller 
Volume 18, Issue 5, Pages (May 2011)
Volume 22, Issue 2, Pages (February 2015)
Volume 7, Issue 11, Pages (November 2000)
Volume 15, Issue 11, Pages (November 2008)
Volume 10, Issue 11, Pages (November 2003)
Volume 16, Issue 5, Pages (May 2009)
Volume 10, Issue 5, Pages (May 2003)
Volume 15, Issue 5, Pages (May 2008)
Volume 20, Issue 11, Pages (November 2013)
Volume 7, Issue 10, Pages (October 2000)
Volume 16, Issue 10, Pages (October 2009)
Volume 8, Issue 1, Pages (January 2001)
Volume 11, Issue 11, Pages (November 2004)
Volume 7, Issue 6, Pages (June 2000)
Volume 11, Issue 10, Pages (October 2004)
Volume 9, Issue 2, Pages (February 2002)
Volume 11, Issue 1, Pages (January 2004)
Volume 22, Issue 6, Pages (June 2015)
Markerless Mutations in the Myxothiazol Biosynthetic Gene Cluster
Volume 15, Issue 6, Pages (June 2008)
Engineered Biosynthesis of Geldanamycin Analogs for Hsp90 Inhibition
Volume 16, Issue 5, Pages (May 2009)
Characterization of the Biosynthetic Gene Cluster for Benzoxazole Antibiotics A33853 Reveals Unusual Assembly Logic  Meinan Lv, Junfeng Zhao, Zixin Deng,
Volume 13, Issue 3, Pages (March 2006)
Volume 11, Issue 3, Pages (March 2004)
Leinamycin Biosynthesis Revealing Unprecedented Architectural Complexity for a Hybrid Polyketide Synthase and Nonribosomal Peptide Synthetase  Gong-Li.
Volume 10, Issue 4, Pages (April 2003)
Biosynthetic Pathway Connects Cryptic Ribosomally Synthesized Posttranslationally Modified Peptide Genes with Pyrroloquinoline Alkaloids  Peter A. Jordan,
Volume 7, Issue 2, Pages (February 2000)
Shifty Ciliates  Lawrence A. Klobutcher, Philip J. Farabaugh  Cell 
Dual Carbamoylations on the Polyketide and Glycosyl Moiety by Asm21 Result in Extended Ansamitocin Biosynthesis  Yan Li, Peiji Zhao, Qianjin Kang, Juan.
Volume 19, Issue 3, Pages (March 2012)
Volume 7, Issue 2, Pages (February 2000)
Volume 14, Issue 6, Pages (June 2007)
Volume 8, Issue 12, Pages (December 2001)
Cloning, Heterologous Expression, and Characterization of the Gene Cluster Required for Gougerotin Biosynthesis  Guoqing Niu, Lei Li, Junhong Wei, Huarong.
Volume 15, Issue 7, Pages (July 2008)
Volume 12, Issue 3, Pages (March 2005)
Volume 11, Issue 1, Pages (January 2004)
Volume 12, Issue 3, Pages (March 2005)
Volume 13, Issue 3, Pages (March 2006)
Volume 12, Issue 10, Pages (October 2005)
Volume 22, Issue 6, Pages (June 2015)
Presentation transcript:

Volume 10, Issue 5, Pages 431-441 (May 2003) A Complete Gene Cluster from Streptomyces nanchangensis NS3226 Encoding Biosynthesis of the Polyether Ionophore Nanchangmycin  Yuhui Sun, Xiufen Zhou, Hui Dong, Guoquan Tu, Min Wang, Bofei Wang, Zixin Deng  Chemistry & Biology  Volume 10, Issue 5, Pages 431-441 (May 2003) DOI: 10.1016/S1074-5521(03)00092-9

Figure 1 Nanchangmycin, the Chemical Structure and Genetic Organization of Its Gene Cluster Top: nanchangmycin [44], a polyether ionophore antibiotic with similar structure to dianemycin. Bold lines indicate the building units used by the PKS for polyketide biosynthesis using acetate (29–30) as a starter followed by condensation steps involving four malonyl and ten methylmalonyl extender units. The carbon atoms of the deoxysugar 4-O-methyl-L-rhodinose attached at C-19 are labeled 1′–6′. Bottom: organization of the nan gene cluster of S. nanchangensis NS3226. The ORFs in orange represent the modular PKS genes, whose organization is detailed above, with purple and red representing the domains of the modules responsible for the loading and extension of a malonate unit (whose specific AT is labeled as ATa), respectively; blue for the extension by a methylmaolonate unit (whose specific AT is labeled as ATp); and green for the CR domain. Black-arrowed ORFs are non-PKS genes, whose proposed functions are detailed in the text and in Table 1. Asterisks indicate inactive domains; two presumably silent DH domains, and one silent ER domain are shown in italics. Chemistry & Biology 2003 10, 431-441DOI: (10.1016/S1074-5521(03)00092-9)

Figure 2 Model for Polyether Biosynthesis of Nanchangmycin in S. nanchangensis NS3226 Each circle represents an enzymatic domain in the PKS polypeptide. The meaning of colors, asterisks, and italics conform to Figure 1. Chemistry & Biology 2003 10, 431-441DOI: (10.1016/S1074-5521(03)00092-9)

Figure 3 Alignment of Active Site Sequences of Grouped Domains from nan PKSs Only the regions containing the proposed active sites are shown. The numbers correspond to the order in the amino acid sequence at the top of each group. Active site residues are marked with asterisks. Conserved motifs important for the function of each domain are underlined. Chemistry & Biology 2003 10, 431-441DOI: (10.1016/S1074-5521(03)00092-9)

Figure 4 Proposed Deoxyhexose (4-O-methyl-L-rhodinose) Biosynthetic Pathway Chemistry & Biology 2003 10, 431-441DOI: (10.1016/S1074-5521(03)00092-9)

Figure 5 Proposed Biosynthetic Pathway and Enzymatic Functionalities Involved in Nanchangmycin Biosynthesis Colors conform to Figure 1. Chemistry & Biology 2003 10, 431-441DOI: (10.1016/S1074-5521(03)00092-9)

Figure 6 In-Frame Deletion of KR6 Resulted in Production of a Nanchangmycin Derivative without a Sugar Moiety The upper part shows the region flanking KR6 (shown in black) in the chromosome of the wild-type strain NS3226, the inhibition against Bacillus cereus 1126, and the LC-MS/MS fragmentation (loss of H2O, ΔH2O) patterns (MS1-MS3 in top, middle, and bottom frames, respectively) of its produced antibiotic nanchangmycin. The lower part shows, for the engineered mutant SYH28, lack of inhibition against Bacillus cereus 1126 and the LC-MS/MS fragmentation (loss of H2O) patterns of its produced nanchangmycin aglycone. The enlarged KR6 section in the middle shows changes before and after in-frame deletion of the 62 aa. The horizontal solid arrows indicate the region corresponding to the synthetic PCR primers (kr-1, 2 for the left and kr-3, 4 for the right arms flanking the deleted region) used for constructing the pHZ1358-derived vector [11] for the in-frame deletion. The restriction sites in parentheses represent engineered specific sequences at the end of PCR primers so as to favor cloning of the PCR products. The amino acid residues in bold highlight the in-frame joining after the expected deletion to form an inactivated KR6 (italics). Chemistry & Biology 2003 10, 431-441DOI: (10.1016/S1074-5521(03)00092-9)